Hilltop National Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Sell
7,504
-127
-2% -$24.9K 0.34% 70
2026
Q1
$1.5M Buy
7,631
+50
+0.7% +$9.71K 0.36% 67
2025
Q4
$1.32M Sell
7,581
-91
-1% -$16.6K 0.32% 78
2025
Q3
$1.46M Sell
7,672
-72
-0.9% -$12.8K 0.36% 68
2025
Q2
$1.39M Buy
+7,744
New +$1.35M 0.36% 68
2024
Q4
$30.2K Hold
200
0.01% 516
2024
Q3
$31.1K Hold
200
0.01% 524
2024
Q2
$27.4K Hold
200
0.01% 527
2024
Q1
$26.6K Buy
+200
New +$25.9K 0.01% 518

Other funds holding DGX

Hilltop National Bank's DGX Position: Q2 2026 in Review

Hilltop National Bank reduced its Quest Diagnostics (DGX) stake by 1.7% in Q2 2026, selling an estimated $24.9K and leaving 7,504 shares worth $1.59M. The position accounts for 0.34% of the portfolio, ranked #70.

Hilltop National Bank first reported a position in DGX in Q1 2024 and has held it in 9 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Hilltop National Bank held 7,504 shares of Quest Diagnostics worth $1.59M as of Q2 2026.
  • Hilltop National Bank sold 127 Quest Diagnostics shares in Q2 2026, an estimated $24.9K.
  • Quest Diagnostics made up 0.34% of Hilltop National Bank's portfolio in Q2 2026, its #70 holding.
  • Hilltop National Bank first reported a position in Quest Diagnostics in Q1 2024 and has held it in 9 quarters since.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.